| Bayer (Schweiz) AG - Kyleena 19.5 mg, Intrauterines Wirkstofffreisetzungssystem | | 66148 | | 01 | | Kyleena 19.5 mg | | Intrauterines Wirkstofffreisetzungssystem | | G02BA03 | | Plastic Iud with Progestogen | | 16.02.2017 | | |
| | Composition | | levonorgestrelum 19.5 mg, poly(dimethylsiloxani) elastomerum, silica colloidalis anhydrica, polyethylenum, barii sulfas, polypropylenum, phthalocyaninum cupricum, argentum, pro praeparatione. | | Packungsbestandteile | | Gestagen abegebendes Intrauterinsystem | | | | | | Active Agent | Dose |
|---|
| Levonorgestrel | 19.5 mg |
| | | | Inactive agents |
|---|
| Argentum | | Barii Sulfas | | Phthalocyaninum Cupricum | | Poly(Dimethylsiloxani) Elastomerum | | Polyethylen | | Polypropylenum | | Silica Colloidalis Anhydrica |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | B | | No |
|
|
